Inverse correlation between plasma Beta-carotene and interleukin-6 in patients with advanced coronary artery disease
Language English Country Singapore Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- alpha-Tocopherol blood MeSH
- beta Carotene blood MeSH
- C-Reactive Protein metabolism MeSH
- Cholesterol blood MeSH
- Interleukin-6 blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Malondialdehyde blood MeSH
- Coronary Artery Disease blood MeSH
- Oxidative Stress physiology MeSH
- Surveys and Questionnaires MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- alpha-Tocopherol MeSH
- beta Carotene MeSH
- C-Reactive Protein MeSH
- Cholesterol MeSH
- Interleukin-6 MeSH
- Malondialdehyde MeSH
The interrelationships between plasma beta-carotene, alpha-tocopherol, and the level of systemic inflammation and oxidative stress were investigated in patients with advanced coronary artery disease (CAD). Plasma beta-carotene, alpha-tocopherol, malondialdehyde, free radicals, interleukin-6, high sensitive C-reactive protein levels, and other risk factors of CAD were determined in a group of patients with advanced CAD [significant stenosis according to coronarographic examination (n=91) and a control group of examined patients with coronary arteries with no stenosis (n=49)]. Between-group differences in continuous variables were analyzed with the Hotelling T2-test (software NCSS2000), analyses of correlation matrix with the software STATISTICA. Advanced CAD coincided with significantly lower plasma concentrations of high-density lipoprotein (HDL)-cholesterol and beta-carotene as well as with elevated levels of all inflammatory markers, but only with mild increase of oxidative stress. Beta-carotene significantly inversely correlated with interleukin-6. This inverse correlation could suggest potential protective effect of beta-carotene on atherosclerosis due to the inhibition of inflammatory processes.
References provided by Crossref.org
ISRCTN
ISRCTN12745004